Neuroscience
Brain
72%
Dopamine
69%
Alzheimer's Disease
63%
In Vivo
49%
Behavior (Neuroscience)
39%
Schizophrenia
39%
Glutamic Acid
37%
Striatum
36%
Neuron
31%
Amphetamine
31%
Dementia
30%
Opiate
28%
Cannabis
23%
Glial Cell Line-Derived Neurotrophic Factor
22%
Placebo
21%
Substance Abuse
21%
Hippocampus
20%
Analeptic
18%
Clozapine
18%
Mild Cognitive Impairment
18%
Parkinson's Disease
18%
Triazolam
17%
Psychiatry
17%
Down Syndrome
17%
Substantia nigra
16%
Depression
16%
Norepinephrine
16%
Human Immunodeficiency Virus
15%
Drug Abuse
14%
Behavioral Effect
14%
Memory
14%
Dopaminergic
14%
Typical Antipsychotic
14%
Prefrontal Cortex
13%
Serotonin
13%
Gene
13%
Cognitive Disorders
13%
Methamphetamine
13%
Blood Plasma
12%
Meta-Analysis
12%
Posttraumatic Stress Disorder
12%
Nicotine
11%
Enzymes
11%
Antipsychotic
11%
Attention Deficit Hyperactivity Disorder
11%
Methylphenidate
11%
Nucleus Accumbens
10%
Cytochrome P450 2D6
10%
Neurotransmitter
10%
Dopamine Release
10%
Risk Behavior
9%
Agonist
9%
Antidepressant
9%
Dopamine Transporter
9%
Major Depressive Disorder
9%
Metabolic Pathway
9%
Addiction
9%
Alcohol Abuse
9%
Cognition
8%
Methadone
8%
Protein
8%
Dorsal Striatum
8%
Monoamine
8%
Oxidopamine
8%
Microdialysis
7%
Impulsivity
7%
Aggression
7%
Functional Magnetic Resonance Imaging
7%
Risperidone
7%
Frontal Lobe
7%
Bipolar Disorder
7%
Central Nervous System
7%
Caudate Nucleus
7%
Caffeine
7%
Olanzapine
6%
Receptor
6%
Catecholamine
6%
Magnetic Resonance Imaging
6%
Tyrosine Hydroxylase
6%
Pharmacokinetics
6%
Putamen
6%
Locus Coeruleus
6%
Tetrahydrocannabinol
6%
Nomifensine
6%
Mood Disorder
6%
Buprenorphine
6%
Cerebellum
6%
Psychosis
6%
Interpersonal Communication
6%
Neurobiology
6%
Epilepsy
6%
Hippocampal Sclerosis
6%
Apomorphine
6%
Seizure
6%
Sensory Gating
5%
Tobacco Dependence
5%
Midbrain
5%
Aripiprazole
5%
Nitric Oxide
5%
In Vitro
5%
Pharmacology, Toxicology and Pharmaceutical Science
Drug
100%
Opiate
69%
Human
67%
Clozapine
58%
Cocaine
51%
Disease
48%
Buprenorphine
36%
Placebo
28%
Pharmacokinetics
27%
Dexamphetamine
24%
Stimulant
21%
Alzheimer's Disease
20%
Triazolam
20%
Schizophrenia
18%
Dopamine
17%
Pharmacodynamics
17%
Methamphetamine
17%
Oxycodone
17%
Typical Antipsychotic
17%
Rat
17%
Cannabis
16%
Symptom
16%
Behavioral Effect
15%
Methylphenidate
15%
Risperidone
15%
Antipsychotic
15%
Ethanol
14%
Normal Human
14%
Amphetamine
14%
Toxic Injury
13%
Case Report
13%
Blindness
13%
Antidepressant
13%
Subjective Effects
13%
Clinical Trial
12%
CYP2D6
12%
Therapeutic Drug Monitoring
12%
Methadone
11%
Pharmacotherapy
11%
Naloxone
10%
Drug Dependence
10%
Myocarditis
9%
Posttraumatic Stress Disorder
9%
Sodium Valproate
9%
Pharmacovigilance
9%
Prevalence
9%
Attention Deficit Disorder
9%
Hydromorphone
9%
Adverse Drug Reaction
8%
Combination Therapy
8%
Olanzapine
8%
Tetrahydrocannabinol
8%
Psychopharmacology
8%
Opioid Overdose
8%
Emergency
8%
Glial Cell Line Derived Neurotrophic Factor
8%
HIV
8%
Parkinson's Disease
8%
Opiate Addiction
8%
Infection
8%
Aripiprazole
7%
Pneumonia
7%
Glutamic Acid
7%
Pharmacogenetics
7%
Serotonin
7%
Death
7%
Depression
7%
Nicotine
7%
Buprenorphine Plus Naloxone
6%
Injury
6%
Addiction
6%
Randomized Clinical Trial
6%
Drug Interaction
6%
Rhesus Monkey
6%
Mortality
6%
Pain
6%
Tramadol
5%
Randomized Controlled Trial
5%
Naltrexone
5%
Receptor
5%
Psychotropic Agent
5%
Animal
5%
Alprazolam
5%
Drug-Drug Interaction
5%
Memantine
5%
Zolpidem
5%
Opiate Agonist
5%
Anticonvulsive Agent
5%
Side Effect
5%
Psychosis
5%
Atomoxetine
5%
Caffeine
5%
Dementia
5%
Monoamine
5%
Modafinil
5%
Polydipsia
5%
Atypical Antipsychotics
5%
Drug Administration
5%
Obesity
5%
Medicine and Dentistry
Therapeutic Procedure
74%
Patient
65%
Drug
32%
Drug Therapy
29%
Child
29%
Evaluation
24%
Opiate
24%
Alzheimer's Disease
23%
Opioid Abuse
22%
Diseases
22%
Buprenorphine
22%
Health
20%
Drug Use
20%
Analysis
19%
Association
18%
Adolescence
18%
Woman
16%
Cocaine
15%
Mental Health
15%
Human Immunodeficiency Virus
15%
Injury
15%
Diagnosis
14%
Clozapine
14%
Adult
14%
Age
14%
Development
14%
Schizophrenia
14%
Symptom
13%
Analeptic
13%
Dementia
12%
Screening
12%
Physician
12%
Experience
11%
Alcohol
11%
Case Report
11%
Substance Abuse
11%
Male
10%
Pediatrics
10%
Person
9%
Psychiatry
9%
Female
9%
Drug Abuse
9%
Aging
9%
Clinical Trial
9%
Human
9%
Systematic Review
8%
Posttraumatic Stress Disorder
8%
Substance Use Disorder
8%
Intoxication
8%
Family
8%
Dopamine
8%
Substance Abuse Treatment
8%
Hospital
8%
Health Care
8%
Pathology
7%
Injection
7%
Laboratory
7%
Mental Health Service
7%
Brain
7%
Placebo
7%
Cannabis
7%
Prevalence
7%
Health Care Cost
7%
Caregiver
7%
Depression
7%
Resident
7%
Health Service
7%
COVID-19
7%
Clinician
6%
Consensus
6%
Syndrome
6%
Measurement
6%
Antipsychotics
6%
Smoking
6%
Older Adult
6%
Outpatient
6%
Dextroamphetamine
6%
Follow up
6%
Methamphetamine
5%
Emergency Department
5%
Randomized Controlled Trial
5%
Comprehension
5%
Researcher
5%
CYP2D6
5%
Parkinson's Disease
5%
High Risk Behavior
5%
Parent
5%
Pain
5%
Tobacco Use
5%
Infection
5%
Down Syndrome
5%
Death
5%